The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma
- PMID: 19479898
- DOI: 10.1002/pros.20988
The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma
Abstract
Background: Three-dimensional culture (3DC) is a relevant in vitro model used to study prostate development and carcinogenesis. Recent studies have indicated that 3DC-associated genes would be more sensitive as prognostic markers for cancer; however, no 3DC-associated genes in prostate cancer (CaP) have thus far been elucidated.
Methods: Candidate 3DC-associated genes in non-malignant prostatic epithelial cells, RWPE-1 and TA2, were selected, based on a comparison of microarray gene expression data between cells grown in two-dimensional culture (2DC) and in 3DC. To extract CaP-associated genes among the 3DC-associated genes, gene expression levels from the microdissected tissue samples were compared between 20 well-differentiated or 20 poorly differentiated CaP, as well as matched normal prostate epithelium. The expression levels of CaP-associated genes in 3DC were validated by quantitative RT-PCR using TA2 cells in 2DC and 3DC. Protein expression of periostin (POSTN), which is one of the 3DC CaP-associated genes, was further evaluated in the clinical samples by immunohistochemistry.
Results: Several genes including POSTN were identified as CaP-associated genes using a 3DC system. Immunohistochemical analyses revealed that POSTN expression was increased in the early stages of CaP (Gleason score 6-7), but not in the advanced stages of CaP. Furthermore, the positive ratio observed for the expression of POSTN in tumor-associated stroma was significantly correlated with the degree of malignancy.
Conclusions: POSTN, one of the 3DC-associated genes, may serve as a potential biomarker for predicting the pathological grade and prognosis of CaP. Prostate 69: 1398-1403, 2009. (c) 2009 Wiley-Liss, Inc.
Similar articles
-
Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.Anticancer Res. 2006 Mar-Apr;26(2A):973-82. Anticancer Res. 2006. PMID: 16619495
-
Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology.Urology. 2010 Apr;75(4):768-72. doi: 10.1016/j.urology.2009.10.026. Epub 2009 Dec 29. Urology. 2010. PMID: 20035976
-
Fibroblast growth factor 17 is over-expressed in human prostate cancer.J Pathol. 2004 Dec;204(5):578-86. doi: 10.1002/path.1668. J Pathol. 2004. PMID: 15538740
-
Prostate cancer and the genomic revolution: Advances using microarray analyses.Mutat Res. 2005 Aug 25;576(1-2):66-79. doi: 10.1016/j.mrfmmm.2004.08.019. Mutat Res. 2005. PMID: 15950992 Review.
-
Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone.Semin Cancer Biol. 2005 Oct;15(5):353-64. doi: 10.1016/j.semcancer.2005.05.005. Semin Cancer Biol. 2005. PMID: 15982899 Review.
Cited by
-
Microfluidic-based human prostate-cancer-on-chip.Front Bioeng Biotechnol. 2024 Jan 23;12:1302223. doi: 10.3389/fbioe.2024.1302223. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38322789 Free PMC article.
-
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.Int J Mol Sci. 2022 Jul 20;23(14):7987. doi: 10.3390/ijms23147987. Int J Mol Sci. 2022. PMID: 35887333 Free PMC article.
-
The multiple facets of periostin in bone metabolism.Osteoporos Int. 2012 Apr;23(4):1199-212. doi: 10.1007/s00198-011-1892-7. Epub 2012 Feb 7. Osteoporos Int. 2012. PMID: 22310955 Review.
-
Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.PLoS One. 2015 Jun 15;10(6):e0130076. doi: 10.1371/journal.pone.0130076. eCollection 2015. PLoS One. 2015. PMID: 26076453 Free PMC article.
-
Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.Oncotarget. 2016 Jan 26;7(4):4036-47. doi: 10.18632/oncotarget.6700. Oncotarget. 2016. PMID: 26716408 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous